CD274 and cancer: Humanized antibodies for PD‐1 or PDL1, such as nivolumab, pembrolizumab, or atezolizumab, have shown promising clinical efficacy for the treatment of melanoma, colon cancer, lung cancer, and several other malignant tumors.4, 5, 6, 7